| CREB phosphorylation through the activation of CaMKII | R-HSA-442729 | 9.08 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 7.85 |
| Visual phototransduction | R-HSA-2187338 | 6.44 |
| Platelet degranulation | R-HSA-114608 | 6.68 |
| Ca-dependent events | R-HSA-111996 | 8.18 |
| Interleukin-2 signaling | R-HSA-451927 | 5.05 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.85 |
| Developmental Biology | R-HSA-1266738 | 3.48 |
| Glucose metabolism | R-HSA-70326 | 6.77 |
| CaM pathway | R-HSA-111997 | 8.28 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.43 |
| Signaling by VEGF | R-HSA-194138 | 4.66 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.32 |
| IRS-mediated signalling | R-HSA-112399 | 4.87 |
| The phototransduction cascade | R-HSA-2514856 | 8.03 |
| Neuronal System | R-HSA-112316 | 4.82 |
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | R-HSA-112314 | 5.85 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.28 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.08 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 |
| beta-catenin independent WNT signaling | R-HSA-3858494 | 5.83 |
| Translocation of GLUT4 to the plasma membrane | R-HSA-1445148 | 6.77 |
| Activation of NMDA receptor upon glutamate binding and postsynaptic events | R-HSA-442755 | 7.7 |
| Signaling by EGFR | R-HSA-177929 | 4.59 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.33 |
| DAP12 interactions | R-HSA-2172127 | 4.56 |
| RHO GTPases activate IQGAPs | R-HSA-5626467 | 8.34 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.28 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.07 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.37 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.98 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.52 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.46 |
| Immune System | R-HSA-168256 | 2.37 |
| eNOS activation | R-HSA-203615 | 9.98 |
| Downstream signal transduction | R-HSA-186763 | 4.65 |
| Ras activation uopn Ca2+ infux through NMDA receptor | R-HSA-442982 | 8.89 |
| Activation of CaMK IV | R-HSA-442745 | 11.98 |
| CREB phosphorylation through the activation of Ras | R-HSA-442742 | 8.23 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.15 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.12 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.14 |
| SOS-mediated signalling | R-HSA-112412 | 5.15 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.14 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.85 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.09 |
| Innate Immune System | R-HSA-168249 | 3.17 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 9.52 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.38 |
| NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
| Prolonged ERK activation events | R-HSA-169893 | 5.11 |
| Signaling by Wnt | R-HSA-195721 | 4.79 |
| PLC beta mediated events | R-HSA-112043 | 7.52 |
| G-protein mediated events | R-HSA-112040 | 7.49 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.15 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.15 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.08 |
| Axon guidance | R-HSA-422475 | 3.93 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.23 |
| Signaling by Leptin | R-HSA-2586552 | 5.1 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.85 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.85 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.73 |
| RHO GTPases activate PAKs | R-HSA-5627123 | 8.59 |
| Cam-PDE 1 activation | R-HSA-111957 | 10.98 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
| Metabolism of carbohydrates | R-HSA-71387 | 4.93 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.26 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.06 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.6 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 5.45 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.15 |
| Frs2-mediated activation | R-HSA-170968 | 5.12 |
| Signalling to RAS | R-HSA-167044 | 5.08 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.89 |
| CREB phosphorylation through the activation of CaMKK | R-HSA-442717 | 10.98 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.15 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.14 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.52 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 9.66 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.15 |
| Opioid Signalling | R-HSA-111885 | 6.64 |
| Ionotropic activity of Kainate Receptors | R-HSA-451306 | 9.66 |
| ARMS-mediated activation | R-HSA-170984 | 5.12 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
| Signaling by PDGF | R-HSA-186797 | 4.53 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.66 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.85 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.34 |
| Signaling by Interleukins | R-HSA-449147 | 4.71 |
| Muscle contraction | R-HSA-397014 | 6.96 |
| Signaling by Rho GTPases | R-HSA-194315 | 4.43 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
| Metabolism | R-HSA-1430728 | 2.34 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.11 |
| Adaptive Immune System | R-HSA-1280218 | 3.19 |
| Calmodulin induced events | R-HSA-111933 | 8.28 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 11.4 |
| DARPP-32 events | R-HSA-180024 | 8.4 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.89 |
| Signalling by NGF | R-HSA-166520 | 4.23 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.15 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.59 |
| Metabolism of nitric oxide | R-HSA-202131 | 8.81 |
| Ca2+ pathway | R-HSA-4086398 | 7.1 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
| Signaling by FGFR | R-HSA-190236 | 4.67 |
| eNOS activation and regulation | R-HSA-203765 | 8.81 |
| Membrane Trafficking | R-HSA-199991 | 5.26 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.9 |
| DAP12 signaling | R-HSA-2424491 | 4.64 |
| Interleukin-3, 5 and GM-CSF signaling | R-HSA-512988 | 4.99 |
| RHO GTPase Effectors | R-HSA-195258 | 4.94 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.14 |
| PLC-gamma1 signalling | R-HSA-167021 | 7.89 |
| Signaling by GPCR | R-HSA-372790 | 2.68 |
| Activation of Kainate Receptors upon glutamate binding | R-HSA-451326 | 8.08 |
| Signalling to ERKs | R-HSA-187687 | 5.04 |
| Hemostasis | R-HSA-109582 | 3.98 |
| Signal Transduction | R-HSA-162582 | 1.78 |